We have shown that the PLEKHA8P1/PLEKHA8 pair confers an oncogenic role through cell proliferation, migration/invasion and wound healing assays, and that it potentially enhances HCC 5-FU-induced chemoresistance. Here, PLEKHA8P1 is linked to hepatocellular carcinoma.